Dara S. Ross

9.0k total citations
58 papers, 1.2k citations indexed

About

Dara S. Ross is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Dara S. Ross has authored 58 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 25 papers in Cancer Research and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Dara S. Ross's work include HER2/EGFR in Cancer Research (28 papers), Breast Cancer Treatment Studies (17 papers) and Breast Lesions and Carcinomas (16 papers). Dara S. Ross is often cited by papers focused on HER2/EGFR in Cancer Research (28 papers), Breast Cancer Treatment Studies (17 papers) and Breast Lesions and Carcinomas (16 papers). Dara S. Ross collaborates with scholars based in United States, Japan and Australia. Dara S. Ross's co-authors include Maria E. Arcila, Edi Brogi, David M. Hyman, Sarat Chandarlapaty, Meier Hsu, Mark G. Kris, Severine Kako, Jamie E. Chaft, Marileila Varella‐Garcia and Bob T. Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Dara S. Ross

56 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dara S. Ross United States	18	725	388	381	361	272	58	1.2k
Regan Fulton United States	17	664 0.9×	253 0.7×	371 1.0×	166 0.5×	250 0.9×	31	1.1k
Daygen L. Finch Canada	15	447 0.6×	880 2.3×	444 1.2×	194 0.5×	335 1.2×	36	1.2k
Xiaoyu Tu China	13	688 0.9×	567 1.5×	305 0.8×	151 0.4×	520 1.9×	39	1.5k
Shigeto Ueda Japan	20	531 0.7×	215 0.6×	508 1.3×	611 1.7×	267 1.0×	43	1.4k
Jeremy Force United States	19	616 0.8×	273 0.7×	588 1.5×	163 0.5×	653 2.4×	49	1.4k
Robert B. Jenkins United States	5	734 1.0×	222 0.6×	440 1.2×	325 0.9×	215 0.8×	8	1.1k
Hyesil Seol South Korea	15	480 0.7×	244 0.6×	307 0.8×	207 0.6×	264 1.0×	34	853
Anna Cardillo Italy	17	734 1.0×	173 0.4×	613 1.6×	151 0.4×	252 0.9×	29	1.1k
Svjetlana Mohrmann Germany	16	588 0.8×	236 0.6×	441 1.2×	222 0.6×	202 0.7×	63	1.1k
Paul Richards United States	20	869 1.2×	266 0.7×	342 0.9×	203 0.6×	281 1.0×	42	1.4k

Countries citing papers authored by Dara S. Ross

Since Specialization

Citations

This map shows the geographic impact of Dara S. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dara S. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dara S. Ross more than expected).

Fields of papers citing papers by Dara S. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dara S. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dara S. Ross. The network helps show where Dara S. Ross may publish in the future.

Co-authorship network of co-authors of Dara S. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Dara S. Ross. A scholar is included among the top collaborators of Dara S. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dara S. Ross. Dara S. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ross, Dara S. & Fresia Pareja. (2024). Molecular Pathology of Breast Tumors. Clinics in Laboratory Medicine. 44(2). 255–275.

Shen, Sherry, Weining Ma, David N. Brown, et al.. (2023). HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer. Modern Pathology. 36(11). 100299–100299. 12 indexed citations

Derakhshan, Fatemeh, Arnaud Da Cruz Paula, Pier Selenica, et al.. (2023). Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization. Modern Pathology. 37(2). 100375–100375. 4 indexed citations

Ntiamoah, Peter, et al.. (2023). Color Standardization and Stain Intensity Calibration for Whole Slide Image-Based Immunohistochemistry Assessment. Microscopy and Microanalysis. 30(1). 118–132. 1 indexed citations

Ntiamoah, Peter, et al.. (2023). Standardizing HER2 immunohistochemistry assessment: calibration of color and intensity variation in whole slide imaging caused by staining and scanning. Han-guk hyeonmigyeong hakoeji/Applied microscopy. 53(1). 8–8. 1 indexed citations

Horvat, João V., Dara S. Ross, Varadan Sevilimedu, et al.. (2023). Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment. Breast Cancer Research and Treatment. 198(2). 349–359. 9 indexed citations

Ross, Dara S. & Timothy M. D’Alfonso. (2022). Papillary Neoplasms of the Breast. Surgical pathology clinics. 15(1). 133–146. 3 indexed citations

Ferguson, Donna C., Amir Momeni Boroujeni, Tao Zheng, et al.. (2021). ERBB2 amplification status in 67 salivary duct carcinomas assessed by immunohistochemistry, fluorescence in situ hybridization, and targeted exome sequencing. Modern Pathology. 35(7). 895–902. 10 indexed citations

Silva, Edaise M. da, Pier Selenica, Mahsa Vahdatinia, et al.. (2021). TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer. npj Breast Cancer. 7(1). 43–43. 18 indexed citations

10.

Schwartz, Christopher J., Fresia Pareja, Edaise M. da Silva, et al.. (2021). Histologic and genomic features of breast cancers with alterations affecting the SWI/SNF (SMARC) genes. Modern Pathology. 34(10). 1850–1859. 5 indexed citations

11.

Ferguson, Donna C., Douglas A. Mata, Timothy Kwang Yong Tay, et al.. (2021). Androgen receptor splice variant-7 in breast cancer: clinical and pathologic correlations. Modern Pathology. 35(3). 396–402. 16 indexed citations

12.

Ulaner, Gary A., Jorge A. Carrasquillo, Christopher C. Riedl, et al.. (2020). Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted ⁸⁹Zr-Pertuzumab PET/CT. Radiology. 296(2). 370–378. 45 indexed citations

13.

Perron, Marjorie, Hannah Y. Wen, Matthew G. Hanna, Edi Brogi, & Dara S. Ross. (2020). HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma: Complete Assessment of an Incomplete Pattern. Archives of Pathology & Laboratory Medicine. 145(8). 979–987. 8 indexed citations

14.

Ross, Dara S., Bo Liu, Alison M. Schram, et al.. (2020). Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients. Annals of Oncology. 31(8). 991–1000. 22 indexed citations

15.

Gupta, Sounak, Chad Vanderbilt, Paolo Cotzia, et al.. (2018). Next-Generation Sequencing–Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer. Journal of Molecular Diagnostics. 21(2). 307–317. 20 indexed citations

16.

Ulaner, Gary A., David M. Hyman, Dara S. Ross, et al.. (2016). Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using ⁸⁹Zr-Trastuzumab PET/CT. Journal of Nuclear Medicine. 57(10). 1523–1528. 144 indexed citations

17.

Ross, Dara S., Ahmet Zehir, Donavan T. Cheng, et al.. (2016). Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status. Journal of Molecular Diagnostics. 19(2). 244–254. 91 indexed citations

18.

D’Alfonso, Timothy M., Dara S. Ross, Yifang Liu, & Sandra J. Shin. (2015). Expression of p40 and laminin 332 in metaplastic spindle cell carcinoma of the breast compared with other malignant spindle cell tumours. Journal of Clinical Pathology. 68(7). 516–521. 12 indexed citations

19.

Li, Bob T., Dara S. Ross, Dara L. Aisner, et al.. (2015). HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers. Journal of Thoracic Oncology. 11(3). 414–419. 212 indexed citations

20.

Ross, Dara S., Yong Wen, & Edi Brogi. (2013). Ductal Carcinoma In Situ. Advances in Anatomic Pathology. 20(4). 205–216. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact